{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:21:24Z","timestamp":1781580084725,"version":"3.54.5"},"reference-count":50,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2018]]},"DOI":"10.17235\/reed.2018.5665\/2018","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:24:29Z","timestamp":1536240269000},"source":"Crossref","is-referenced-by-count":7,"title":["Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment"],"prefix":"10.17235","volume":"110","author":[{"given":"Albert","family":"Par\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Jes\u00fas","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\ufffd","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6910","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.041"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Par\u00e9s A. Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid? Clin Liver Dis; 2014;3(2):29\ufffd33.","DOI":"10.1002\/cld.311"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2010.07.006"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.02.019"},{"key":"ref5","unstructured":"5. Orphanet Report Series. Prevalencia de las enfermedades raras?: Datos bibliogr\u00e1ficos Enfermedades listadas por orden de prevalencia o incidencia decreciente o por n\u00famero de casos publicados [Internet]. [cited 2016 Dec 12]. Available from: http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/ES\/Prevalencia_de_las_enfermedades_raras_por_prevalencia_decreciente_o_casos.pdf"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis. NIH Public Access; 2014;34(3):265\ufffd72.","DOI":"10.1055\/s-0034-1383726"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci058"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22906"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Al-Harthy N, Kumagi T. Natural history and management of primary biliary cirrhosis. Hepat Med. Dove Press; 2012;4:61\ufffd71.","DOI":"10.2147\/HMER.S25998"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-858281"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04410-8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22428"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Lammers WJ, van Buuren HR, Hirschfield GM, et.al. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study. Gastroenterology. 2014;147(6):1338\ufffd1349.e5.","DOI":"10.1053\/j.gastro.2014.10.032"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.009"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.1999.tb00020.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.005"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.216"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02678.x"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Gali\u00e8 N, Humbert M, Vachiery J-L, et.al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016 Jan;37(1):67\ufffd119.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1256-1"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Nevens F, Andreone P, Mazzella G, et.al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med. Massachusetts Medical Society; 2016;375(7):631\ufffd43.","DOI":"10.1056\/NEJMc1611913"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Akamatsu N, Sugawara Y. Primary biliary cirrhosis and liver transplantation. Intractable rare Dis Res. International Advancement Center for Medicine & Health Research Co.; 2012;1(2):66\ufffd80.","DOI":"10.5582\/irdr.2012.v1.2.66"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i33.1419"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16365"},{"key":"ref28","unstructured":"28. EMA (European Medicines Agency). Summary of Product Characteristics. Ocaliva. 2016 [cited 2017 Nov 12];1\ufffd26. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004093\/WC500218418.pdf"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12281"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328277594a"},{"key":"ref31","unstructured":"31. Registro Nacional de Enfermedades colest\u00e1sicas y autoinmunes hep\u00e1ticas (ColHai) | AEEH [Internet]. [cited 2017 Nov 28]. Available from: http:\/\/aeeh.es\/2016\/11\/registro-nacional-de-enfermedades-colestasicas-y-autoinmunes-hepaticas-colhai\/"},{"key":"ref32","unstructured":"32. Caballero Plasencia AM, L\u00f3pez Callejas C, Valenzuela Barranco M, et.al. [Epidemiology of primary biliary cirrhosis in the South area of Granada]. Med Clin (Barc). 1991;96(13):481\ufffd5."},{"key":"ref33","unstructured":"33. Moreno S\u00e1nchez D, Cassinello Ogea C, Gonz\u00e1lez Blanco P, et.al. [Epidemiology of primary biliary cirrhosis in southern Madrid]. Med Clin (Barc). 1990;94(15):564\ufffd9."},{"key":"ref34","unstructured":"34. Borda F, Huarte MP, Zozaya JM, et.al. [Primary biliary cirrhosis in Navarra]. An Med Interna. 1989;6(2):63\ufffd6."},{"key":"ref35","unstructured":"35. Par\u00e9s A, Bruguera M, Rod\u00e9s J, et.al. [Epidemiology of primary biliary cirrhosis in Cataluna]. Med Clin (Barc). 1984;82(6):237\ufffd41."},{"key":"ref36","unstructured":"36. Rodrigo S\u00e1ez L, Valerdiz Casasola CS, Rodr\u00edguez Garc\u00eda M, et.al. [Epidemiology of primary biliary cirrhosis in Asturias]. Med Clin (Barc). 1987;88(12):486\ufffd9."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/13611260500069947"},{"key":"ref38","unstructured":"38. Albi Espa\u00f1a Asociaci\u00f3n para la lucha contra las enfermedades biliares inflamatorias [Internet]. [cited 2017 Nov 28]. Available from: http:\/\/www.albi-espana.org\/"},{"key":"ref39","unstructured":"39. AEEH | Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado [Internet]. [cited 2017 Nov 28]. Available from: http:\/\/aeeh.es\/"},{"key":"ref40","unstructured":"40. Orphanet. Orphan Drugs in Europe [Internet]. [cited 2017 Feb 3]. Available from: http:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Education_AboutOrphanDrugs.php?lng=EN&stapage=ST_EDUCATION_EDUCATION_ABOUTORPHANDRUGS_EUR"},{"key":"ref41","unstructured":"41. INE. Instituto Nacional de Estad\u00edstica [Internet]. [cited 2017 Jun 13]. Available from: http:\/\/www.ine.es\/"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12434"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.06.015"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/00365520701396034"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000257"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23210"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn043"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref49","unstructured":"49. Comisi\u00f3n Interministerial de Precios de los Medicamentos. Nota informativa de la reuni\u00f3n de la comisi\u00f3n interministerial de precios de los medicamentos. Sesi\u00f3n 177 de 6 de noviembre de 2017. 2017 [cited 2018 Mar 20]; Available from: https:\/\/www.msssi.gob.es\/profesionales\/farmacia\/pdf\/ACUERDOS_DE_LA_CIPM_177_web.pdf"},{"key":"ref50","unstructured":"50. AEMPS. Ficha t\u00e9cnica Ocaliva 5 mg comprimidos recubiertos con pel\u00edcula [Internet]. [cited 2018 Mar 15]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1161139001\/FT_1161139001.html"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T21:04:55Z","timestamp":1661979895000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=685767743237-414279197169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":50,"URL":"https:\/\/doi.org\/10.17235\/reed.2018.5665\/2018","relation":{},"ISSN":["1130-0108"],"issn-type":[{"value":"1130-0108","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}